Spyridoula Vasileiou, PhD, discusses the potential role of ALVR109, a SARS-CoV-2 virus–specific T-cell therapy, for the treatment of coronavirus disease 2019.
Latest Conference Coverage
Advertisement
The study presented at AAO provides an update on previously shared 6-month data from earlier this year.
Advertisement
Advertisement
Advertisement
Trending on CGTlive®
1
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
2
Crawford Strunk, MD, on the Importance of Palliative Care in Sickle Cell Disease
3
The Importance of Palliative Care in Sickle Cell Disease
4
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
5
